{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:15:19Z","timestamp":1778919319772,"version":"3.51.4"},"publisher-location":"New York, NY","reference-count":12,"publisher":"Springer US","isbn-type":[{"value":"9781071647370","type":"print"},{"value":"9781071647387","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-4738-7_12","type":"book-chapter","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:27:25Z","timestamp":1759271245000},"page":"173-184","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utilization of Induced Pluripotent Stem Cell-Derived Neurons to Investigate the Splice-Modification Efficacy of Splice-Switching Drug Candidates"],"prefix":"10.1007","author":[{"given":"Yukiko","family":"Ueta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonari","family":"Awaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masatoshi","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"12_CR1","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1056\/NEJMoa1702752","volume":"377","author":"RS Finkel","year":"2017","unstructured":"Finkel RS, Mercuri E, Darras BT et al (2017) Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med 377:1723\u20131732. https:\/\/doi.org\/10.1056\/NEJMoa1702752","journal-title":"N Engl J Med"},{"issue":"5","key":"12_CR2","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1056\/NEJMoa2102047","volume":"385","author":"BT Darras","year":"2021","unstructured":"Darras BT, Masson R, Mazurkiewicz-Be\u0142dzi\u0144ska M et al (2021) Risdiplam-treated infants with type 1 spinal muscular atrophy versus historical controls. N Engl J Med 385(5):427\u2013435. https:\/\/doi.org\/10.1056\/NEJMoa2102047","journal-title":"N Engl J Med"},{"issue":"3","key":"12_CR3","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/ijms26031303","volume":"26","author":"M Matsuo","year":"2025","unstructured":"Matsuo M (2025) 30 years since the proposal of exon skipping therapy for Duchenne muscular dystrophy and the future of pseudoexon skipping. Int J Mol Sci 26(3):1303. https:\/\/doi.org\/10.3390\/ijms26031303","journal-title":"Int J Mol Sci"},{"key":"12_CR4","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","volume":"131","author":"K Takahashi","year":"2007","unstructured":"Takahashi K, Tanabe K, Ohnuki M et al (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861\u2013872. https:\/\/doi.org\/10.1016\/j.cell.2007.11.019","journal-title":"Cell"},{"issue":"S3","key":"12_CR5","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1111\/epi.16395","volume":"60","author":"IE Scheffer","year":"2019","unstructured":"Scheffer IE, Nabbout R (2019) SCN1A-related phenotypes: epilepsy and beyond. Epilepsia 60(S3):S17\u2013S24. https:\/\/doi.org\/10.1111\/epi.16395","journal-title":"Epilepsia"},{"issue":"558","key":"12_CR6","doi-asserted-by":"publisher","first-page":"eaaz6100","DOI":"10.1126\/scitranslmed.aaz6100","volume":"12","author":"Z Han","year":"2020","unstructured":"Han Z, Chen C, Christiansen A et al (2020) Antisense oligonucleotides increase Scn1a expression and reduce seizures and SUDEP incidence in a mouse model of Dravet syndrome. Sci Transl Med 12(558):eaaz6100. https:\/\/doi.org\/10.1126\/scitranslmed.aaz6100","journal-title":"Sci Transl Med"},{"issue":"9","key":"12_CR7","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1073\/pnas.1415525112","volume":"112","author":"M Yoshida","year":"2015","unstructured":"Yoshida M, Kataoka N, Miyauchi K et al (2015) Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia. Proc Natl Acad Sci USA 112(9):2764\u20132769. https:\/\/doi.org\/10.1073\/pnas.1415525112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"12_CR8","doi-asserted-by":"publisher","first-page":"4507","DOI":"10.1038\/s41467-021-24705-5","volume":"12","author":"M Ajiro","year":"2021","unstructured":"Ajiro M, Awaya T, Kim YJ et al (2021) Therapeutic manipulation of IKBKAP mis-splicing with a small molecule to cure familial dysautonomia. Nat Commun 12(1):4507. https:\/\/doi.org\/10.1038\/s41467-021-24705-5","journal-title":"Nat Commun"},{"key":"12_CR9","doi-asserted-by":"publisher","first-page":"11329","DOI":"10.1073\/pnas.0604616103","volume":"103","author":"T Fukuhara","year":"2006","unstructured":"Fukuhara T, Hosoya T, Shimizu S et al (2006) Utilization of host SR protein kinases and RNA-splicing machinery during viral replication. Proc Natl Acad Sci 103:11329\u201311333. https:\/\/doi.org\/10.1073\/pnas.0604616103","journal-title":"Proc Natl Acad Sci"},{"key":"12_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ncomms1306","volume":"2","author":"A Nishida","year":"2011","unstructured":"Nishida A, Kataoka N, Takeshima Y et al (2011) Chemical treatment enhances skipping of a mutated exon in the dystrophin gene. Nat Commun 2:308. https:\/\/doi.org\/10.1038\/ncomms1306","journal-title":"Nat Commun"},{"key":"12_CR11","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1016\/j.chembiol.2020.08.013","volume":"27","author":"S Shibata","year":"2020","unstructured":"Shibata S, Ajiro M, Hagiwara M (2020) Mechanism-based personalized medicine for cystic fibrosis by suppressing pseudo exon inclusion. Cell Chem Biol 27:1472\u20131482.e6. https:\/\/doi.org\/10.1016\/j.chembiol.2020.08.013","journal-title":"Cell Chem Biol"},{"key":"12_CR12","doi-asserted-by":"publisher","unstructured":"Nakano-Kobayashi A, Fukumoto A, Morizane A, Nguyen DT, Le TM, Hashida K, Hosoya T, Takahashi R, Takahashi J, Hori O, Hagiwara M (2020) Therapeutics potentiating microglial p21-Nrf2 axis can rescue neurodegeneration caused by neuroinflammation. Sci Adv 6(46):eabc1428. https:\/\/doi.org\/10.1126\/sciadv.abc1428","DOI":"10.1126\/sciadv.abc1428"}],"container-title":["Methods in Molecular Biology","Splice Switching"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4738-7_12","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:58:42Z","timestamp":1778918322000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4738-7_12"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"ISBN":["9781071647370","9781071647387"],"references-count":12,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4738-7_12","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"1 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}